Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2000, p. 8879-8888, Vol. 20, No. 23
Laboratory of Genetics, National Institute on
Aging, National Institutes of Health, Baltimore, Maryland
212241; Department of Molecular and Cell
Biology, Howard Hughes Medical Institute, University of California,
Berkeley, California 947202; and
Laboratory of Reproductive and Developmental Toxicology,
National Institute of Environmental Health Sciences, Research
Triangle Park, North Carolina 277093
Received 15 June 2000/Returned for modification 13 July
2000/Accepted 13 September 2000
The SWI/SNF family of chromatin-remodeling complexes facilitates
gene activation by assisting transcription machinery to gain access to
targets in chromatin. This family includes BAF (also called hSWI/SNF-A)
and PBAF (hSWI/SNF-B) from humans and SWI/SNF and Rsc from
Saccharomyces cerevisiae. However, the relationship between the human and yeast complexes is unclear because all human subunits published to date are similar to those of both yeast SWI/SNF
and Rsc. Also, the two human complexes have many identical subunits,
making it difficult to distinguish their structures or functions. Here
we describe the cloning and characterization of BAF250, a subunit
present in human BAF but not PBAF. BAF250 contains structural
motifs conserved in yeast SWI1 but not in any Rsc components,
suggesting that BAF is related to SWI/SNF. BAF250 is also a homolog of
the Drosophila melanogaster Osa protein, which has been
shown to interact with a SWI/SNF-like complex in flies.
BAF250 possesses at least two conserved domains that could be important
for its function. First, it has an AT-rich DNA interaction-type DNA-binding domain, which can specifically bind a DNA sequence known to be recognized by a SWI/SNF family-related complex at the
0270-7306/00/$04.00+0
A Specificity and Targeting Subunit of a Human
SWI/SNF Family-Related Chromatin-Remodeling Complex
-globin locus. Second, BAF250 stimulates glucocorticoid
receptor-dependent transcriptional activation, and the stimulation
is sharply reduced when the C-terminal region of BAF250 is
deleted. This region of BAF250 is capable of interacting directly with
the glucocorticoid receptor in vitro. Our data suggest that BAF250
confers specificity to the human BAF complex and may recruit the
complex to its targets through either protein-DNA or protein-protein interactions.
*
Corresponding author. Mailing address: Laboratory of
Genetics, National Institute on Aging, National Institutes of Health, 333 Cassell Dr., TRIAD Center Room 4000, Baltimore, MD 21224. Phone:
(410) 558-8334. Fax: (410) 558-8331. E-mail:
wangw{at}grc.nia.nih.gov.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|